New Delhi, February 14 Piramal Pharma has stated that the US health regulator has issued a Form 483 with four observations after inspecting its manufacturing plant based in Telangana.The US Food and Drug Administration (USFDA) conducted an inspection of the company's plant in Digwal...
New Delhi, February 10 Drug maker Cipla said that the US health regulator has issued Form 483 with two observations after inspecting a manufacturing facility of its US-based unit, InvaGen Pharmaceuticals, Inc.A Pre-Approval Inspection was conducted by the US Food and Drug Administration...